Respiratory and Intensive Care Medicine, Hôtel-Dieu, Paris Descartes University, Paris, France.
Curr Opin Pulm Med. 2010 Mar;16(2):112-7. doi: 10.1097/MCP.0b013e328335f039.
Exacerbations have a major short-term and long-term impact on patients with chronic obstructive pulmonary disease (COPD). Risk stratification of patients presenting to the emergency department for an exacerbation of COPD is of utmost importance to help in deciding patients' orientation and treatment and in improving outcomes.
Studies on predictors of outcomes of COPD exacerbations are markedly heterogeneous in terms of assessed variables, outcomes of interest and timeframe (short-term vs. long-term outcomes). Age, severity of underlying disease, clinical signs of immediate severity, and comorbidities are among the most frequently identified prognostic factors of in-hospital outcome. In the most severe patients, ICU scores such as the Acute Physiology and Chronic Health Evaluation II (APACHE II) also have a prognostic value. Several biomarkers have also been studied, but their additional value for risk stratification is not clarified.
Scores predicting the risk of poor outcome could prove useful in the management of COPD exacerbations. Some have been suggested but remain to be further validated before their use can be generalized.
慢性阻塞性肺疾病(COPD)患者的急性加重对其短期和长期均有重大影响。对因 COPD 急性加重而就诊于急诊科的患者进行风险分层对于帮助决定患者的去向和治疗以及改善预后至关重要。
有关 COPD 急性加重结局预测因素的研究在评估变量、关注结局和时间框架(短期和长期结局)方面差异很大。年龄、基础疾病严重程度、急性严重程度的临床体征和合并症是住院结局最常确定的预后因素之一。对于最严重的患者,急性生理学和慢性健康评估 II 评分(APACHE II)等 ICU 评分也具有预后价值。也研究了一些生物标志物,但它们对风险分层的额外价值尚未明确。
预测不良结局风险的评分可能有助于 COPD 急性加重的管理。已经提出了一些评分,但在广泛应用之前还需要进一步验证。